Evidence map›Paper›PMID 35260440›Full record

ArticleNeurology2022

Etiology and Outcome of Ischemic Stroke in Patients With Renal Impairment Including Chronic Kidney Disease: Japan Stroke Data Bank.

Kaori Miwa, Masatoshi Koga, Michikazu Nakai, Sohei Yoshimura, Yusuke Sasahara, Junpei Koge, Kazutaka Sonoda, Akiko Ishigami, Yoshitaka Iwanaga, Yoshihiro Miyamoto and 4 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Clinical impact of body mass index on outcomes of ischemic and hemorrhagic strokes.International journal of stroke : official journal of the International Stroke Society · 2024
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Kaori MiwaFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.ORCID 0000-0002-7948-3636
Masatoshi KogaFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.ORCID 0000-0002-6758-4026
Michikazu NakaiFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.
Sohei YoshimuraFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.
Yusuke SasaharaFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.
Junpei KogeFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.
Kazutaka SonodaFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.
Akiko IshigamiFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.
Yoshitaka IwanagaFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.
Yoshihiro MiyamotoFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.
Shotai KobayashiFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.
Kazuo MinematsuFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.
Kazunori ToyodaFrom the Department of Cerebrovascular Medicine (K.M., M.K., S.Y., J.K., A.I., K.T.) and Center for Cerebral and Cardiovascular Disease Information (M.N., Y.S., Y.I., Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka; Department of Neurology (K.S.), Saiseikai Fukuoka Hospital, Fukuoka; Shimane University School of Medicine (S.K.), Izumo; and Medical Corporation ISEIKAI (K.M.), Osaka, Japan.ORCID 0000-0002-8346-9845
Japan Stroke Data Bank Investigators
National Cerebral and Cardiovascular Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesChronic kidney disease is a worldwide public health problem that is recognized as an established risk factor for stroke. It remains unclear whether its distribution and clinical impact are consistent across ischemic stroke subtypes in patients with renal impairment. We examined whether renal impairment was associated with the proportion of each stroke subtype vs ischemic stroke overall and with functional outcomes after each stroke subtype.

methodsStudy participants were 10,392 adult patients with an acute stroke from the register of the Japan Stroke Data Bank, a hospital-based multicenter stroke registration database, between October 2016 and December 2019, whose baseline serum creatinine levels or a dipstick proteinuria result were available. All ischemic strokes were classified according to the Trial of Org 10172 in Acute Stroke Treatment criteria. Unfavorable functional outcome was defined as modified Rankin Scale (mRS) score 3-6 at discharge. Mixed effect logistic regression was used to determine the relationship between the outcomes and the estimated glomerular filtration rate (eGFR), eGFR strata (<45, 45-59, ≥60 mL/min/1.73 m

resultsOverall, 2,419 (23%) patients had eGFR 45-59 mL/min/1.73 m DISCUSSION: Renal impairment contributes to the different distributions and clinical effects across specific stroke subtypes, particularly evident in cardioembolic stroke and small vessel occlusion. This possibly indicates shared mechanisms of susceptibility and potentially enhancing pathways.

Indexed as

Embolic StrokeIschemic StrokeRenal Insufficiency, ChronicStrokeAdultFemaleHumansJapanMaleProteinuria

Identifiers

PMID35260440
PMCPMC9071372
OpenAlexW4220876381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.